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ABSTRACT 
Yermakoff, Jeannee Karen. M.S., University of Rhode 
Island, 1978. An Experimental Model of Hepatic Fibrosis 
Induced by the Administration of Dibutyltin Dichloride. 
Major Professor: Dr. George C. Fuller. 
Dibutyltin dichloride (DBT}, one of a series of dialkyl-
tin derivatives used industrially as polyvinylchloride 
stabilizers and urethane catalysts, was investigated for its 
I 
ability to induce liver fibrosis in rats. 
Collagen, the predominant protein in fibrotic tissue, 
is synthesized in a series of sequential steps consisting 
of assembly of a proline-rich and lysine-rich polypeptide 
precursor of collagen, enzymatic hydroxylation of some of 
the prolyl and lysyl residues, and glycosylation of some of · 
the hydroxylysyl residues. Since prolyl residues are not 
hydroxylated before they are in peptide-bound form, the 
conversion of isotopically labeled proline to hydroxyproline 
by prolyl hydroxylase was taken as one parameter reflecting 
the rate of collagen formation. In vitro collagen synthesis 
was determined by incubation of liver biopsies with labeled 
proline, after which incorporation of label into collagenase 
digestible protein is compared to incorporation into col-
lagenase-resistant protein. Hydroxyproline content served 
as a parameter of increased collagen accumulation, since 
hydroxyproline does not appear in significant amounts in 
noncollagen protein. 
ii 
DBT was administered by oral intubation (10 and 20 mg/kg) 
every other day for 12 days. Histopathological observation 
in these rats revealed extensive inflammation in portal 
tracts, bile duct inflammation and proliferation, fibrosis, 
necrosis, infarcted areas and granulomatous lesions. In the 
higher dose group, a greater than two-fold increase in 
hydroxyproline content, a greater than 50% increase in prolyl 
hydroxylase activity and a two-fold increase in relative 
collagen synthesis in vitro was observed at the end of the 
12 day ·period. 
DBT, administered by oral intubation (10 and 2·0 mg/kg) 
daily for four days, produced inflammation of portal tracts 
and bile duct inflammation and pro.l .iferation. Prolyl 
hydroxylase was increased 50 and 130% over control values 
in the · 10 and 20 mg/kg groups, respectively. In vitro 
collagen synthesis increased approximately five-fold in the 
higher dose group. However, there was no increase in 
relative collagen synthesis due to a concomitant elevation 
in noncollagen protein, probably as a result of inflam-
matory cell protein synthesis. 
DBT (J x 10-7 and J x lo-6 M) had no effect on prolyl 
hydroxylase activity of 1929 mouse fibroblasts in cell 
culture. 
iii 
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INTRODUCTION 
The toxicity of alkyltin derivatives has been 
recognized for some time. Intensive investigation of 
the biological effects of alkyltin compounds began in 
the mid 1950's in response to increased industrial use 
of these compounds and a disaster in France caused by 
the inclusion of an alkyltin derivative in a preparation 
for the treatment of skin infections. Currently, di-
alkyl tin compounds are widely used as polyvinylchloride ·-
stabilizers in medicinall~used plastics, the biological 
inertness of which has been questioned. 
Dialkyltin derivatives produce hepatic and biliary 
damage (Barnes and Stoner, 1958; Barnes and Magee, 1958; 
Gaunt et al., 1968). Barnes and Magee (1958) reported 
hepatic . fibrosis in rats in addition to inflammation and 
bile duct injury following the administration of dibutyl-
tin dichloride (DBT). 
Hepatic fibrosis has long been recognized as one 
of the sequelae of inflammation and chemically-induced 
liver damage. This investigation was conducted to 
determine the fibrogenic potential of DBT in rat liver 
and the relationship of th-is fibrogenesis to associated 
histopathological changes. In vivo and in vitro labora-
tory models were employed for measurement of hepatic 
1 
collagen synthesis following the oral administration 
of DBT. 
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LITERATURE SURVEY 
Collagen Biosynthesis 
Collagen, the fibrous protein component of connective 
tissue, is present in the extracellular matrix as rigid 
fibers made up of cross-linked collagen molecules. These 
molecules each consist of three polypeptide chains coiled 
into a unique left-handed triple helix• Five different 
types of polypeptide chains, called a. chains, have been 
characterized in four different types of collagen (Crystal, 
19741 Miller, 1976). Type I collagen, found primarily in 
bone and skin, consists of two a. 1 chains and one a. 2 
chain, which are distinguishable by their separation on 
carboxymethylcellulose columns, and is represented as 
[a. 1 (I) ] 2 2. The remaining three types of collagen each 
consist of three identical a.l chains, with each type of 
a. 1 chain differing slightly in amino acid composition. 
Type II collagen ([ a.l(II)]3) is found primarily in 
cartilage; type III ([a. l(III)]3 ) in fetal tissue, muscle, 
and aorta; and type IV ([a. l(IV)]3 ) in basement membranes. 
Collagen biosynthesis consists of the assembly of 
a proline- and lysine-rich polypeptide precursor of collagen, 
proc ollagen, which is subse.q uently modified by a number of 
J 
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post-translational modifications. Hydroxylation of both 
proline (Prockop and Juva, 1965) and lysine (Sinex et al., 
1959) has been shown to occur subsequent to incorporation 
of these amino acids into procollagen chains. Following 
hydroxylation of lysine, some of these residues are glyco-
sylated to galactosylhydroxylysine and glucosylgalactosyl-
hydroxylysine (Spiro and Spiro, 1971, 197la, and 197lb). 
Cellular processing of procollagen a chains also 
includes interchain disulfide-bond linkage in non-helical 
regions of the molecule (Bornstein, 1974) which is essential 
for triple-helix formation (Speakman, 1971). Following the 
secretion of procollagen, these non-helical regions are 
removed by the extracellular enzyme, procollagen peptidase 
(Lapiere et al., 197ls Goldberg et.!!•• 1975). Collagen 
cross~linking occurs through additional extracellular 
processing by the enzyme lysyl oxidase which oxidatively 
deaminates specific lysine residues leaving aldehyde 
moieties which form cross links through condensation 
reactions (Siegal et al., 1970). 
Hepatic Fibrosis in Liver Disease 
Collagen is the most abundant protein in the human 
body and the major protein of connective tissue. Normal 
liver, however, contains only a small amount of connective 
tissue. Hepatic fibrosis defines an excess of collagenous 
5 
fibrous tissue in the liver (Leevy et al., 1976). In-
creased collagen content in human and experimental liver 
disease leading to cirrhosis has been established by 
histological observation and chemical determination of 
hydroxyproline (Kent et al., 1959). Excess collagen 
accumulation may occur subsequent to the collapse of 
preformed collagen fibers or from formation of new fibers. 
However, collapse and aggreg~tion of existing fibrous 
tissue . following hepatocyte necrosis are thought to play 
a minor role in hepatic fibrosis compared to formation of 
new fibers (Popper and Udenfrlend, 1970). Increased 
de n.QYQ synthesis of collagen has been associated with 
the accumulation of collagen in experimental cirrhosis 
(Huberman et al., 1969) • 
. --
An increase in hepatic collagen may result from one 
or a combination of three processes: increased collagen 
biosynthesis; increased maturation (cross-linking), fibril 
formation and deposition of collagen; and decreased 
catabolism of fibers. 
Increased collagen biosynthesis has been demonstrated 
as increased activity of the intracellular enzyme prolyl 
hydroxylase in experimental (Takeuchi et al., 1976) and 
human cirrhosis (Fuller et al., 1976; Fuller et al., 1977). 
Additional evidence for increased collagen biosynthesis 
in hepatic fibrosis has been obtained by measurement of 
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in vitro incorporation of labeled proline into collagen 
in human (Chen and Leevy, 1976) and experimental (Rodjkind 
and Diaz De Leon, 1970) liver biopsies. Increased collagen 
biosynthesis has also been correlated with an increase in 
the free proline pool and concomitant decrease in the amount 
of free glutamic acid, a precursor of proline, in both 
experimental (Rodjkind and Diaz De Leon, 1970) and human 
cirrhosis (Kershinobich et al., 1970). Fibroblasts were 
long thought to be responsible for increased collagen bio-
synthesis in hepatic fibrosis. Recently, however, enzymes 
responsible for collagen biosynthesis have been found in 
many nonfibroblastic cell lines in culture (Langness and 
Udenfriend, 1974). In the liver, vitamin A-containing 
perisinusoidal cells (Ito cells or lipocytes) have been 
implicated in fibrogenesis by serving as resting precursors 
of fibroblasts (Kent et al., 1976). 
Increased extracellular maturation and deposition 
of collagen may occur in hepatic fibrosis due to the 
increased availability of surfaces with reduced solid and 
fluid exchange, which serve as anchors for collagen fibers 
(Popper and Udenfriend, 1970). Structures which may 
contain surfaces such as these include the sinusoidal 
surface of damaged hepatocytes and the basement membranes 
of proliferated bile ductules and capillaries. 
The role of collagen resorption in hepatic fibrosis 
remains to be established. Extracellular collagenase in 
the liver has been observed by immunohistochemical 
methods primarily in the liver capsule and portal tracts 
(Montfort and Perez-Tamayo, 1975); intracellular colla-
genase in an active form has been reported to be present 
in Kupffer cells of the hepatic reticuloendothelial 
system (Fujiwara et al., 197)). Hepatic collagenase 
activity has been reported to be increased in carbon 
tetrachloride-induced experimental fibrosis, primarily 
in the subacute stage of treatment (Okazaki and Marujama, 
1974). 
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Necrosis and inflammation may be primary stimuli of 
fibrogenesis. The hypothesis that hepatocyte death is 
fibrogenic has been accepted for some time (Aterman, 1954). 
Hepatic necrosis has been associated with fibrogenesis in 
studies with such compounds as carbon tetrachloride 
(Cameron and Karunaratne, 1936) and dimethylnitrosamine 
(Madden et al., 1970). Death of hepatocytes has been 
thought to cause fibrogenesis by release of either macro-
or micromolecular products from these cells (Popper, 1975). 
Inflammation has been implicated as a precursor to f ibro-
genesis. Pharmacologically active compounds formed by 
inflammatory cells may act as stimuli of fibrogenesis 
(Popper, 1975). Immune complexes have been suggested as 
stimuli of fibrogenesis, since localization of such com-
plexes in portal tracts preceded the development of 
cirrhosis in rats induced by immunization with heter-
ologous sera (Paronetto and Popper, 1966). 
Conversely, necrotic and inflammatory processes 
often associated with hepatic fibrosis may be initiated 
by the functional changes resulting from collagen accumu-
lation. Anoxic injury to hepatocytes occurs from 
fibrosis and the associated circulatory impairment; the 
resulting breakdown products of dead hepatocytes may in 
turn be responsible for stimulation of the inflammatory 
process. 
Organotin Toxicity 
8 
Organotin derivatives have demonstrated usefulness 
as biocidal compounds, heat stabilizers and catalytic 
agents (Piver, 197)). Dialkyltin compounds are used 
primarily as heat stabilizers and catalysts in poly-
vinylchloride and polyurethane production, respectively; 
trialkyl- and triaryltin derivatives are employed as 
biocidal agents. Such applications of organotin compounds 
have resulted in increased industrial use whereby these 
compounds are now the fourth largest group of organo-
metallics produced. 
Dibutyltin derivatives have not been sanctioned by 
the Food and Drug Administration for use in plastics 
which come in contact with food; dioctyltin compounds 
have been developed for this purpose (Piver, 197)). 
However, dibutyltin derivatives are widely used as poly-
vinylchloride stabilizers in medicinally-used plastics. 
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The biological inertness of plastics used in the medical, 
dental and pharmaceutical professions has been questioned 
(Nimni, 1964; Guess and Stetson, 1968; Guess and Haberman, 
1968). Organotin-containing polyvinylchloride plastics 
implanted both intramuscularly. and subcutaneously in 
rats and rabbits causes a local tissue reaction mani-
fested by necrosis, proliferation of granulation tissue 
and encapsulation by fibrous tissue (Nimni, 1964). 
Injection of extracts of these plastics and dilutions 
of up to lsl0,000 of dibutyltin dilaurate produced a 
similar inflammatory response implicating dibutyltin 
dilaurate as the toxic component. Guess and Haberman 
(1968) investigated the toxicity of plastics and their 
additives by cell culture techniques. All ten of the 
dibutyltin stabilizers studied demonstrated some degree 
of toxicity. 
Extensive investigation of the toxicity of organotin 
derivatives began in the mid 1950's. The impetus for 
this was the increased industrial use of these compounds 
and the "Stalinon" disaster in France in 1954 (Barnes 
and .Stoner, 1961). "Stalinon" was a preparation sold 
for the treatment of staphylococcal skin infections, 
which was said to contain 15 mg diethyltin diiodide and 
100 mg linoleic acid per capsule, but later was found to 
contain large quantities of mono- and triethyltin. The 
10 
recommended dose was six capsules per day for eight days. 
Two hundred and seventeen poisonings resulting in 100 
deaths were reported due to "Stalinon". Symptoms included 
persistent headache, vertigo, visual and psychic disturb-
ances, vomiting and abdominal pain. Autopsy revealed 
interstitial cerebral edema and some venous endothelial 
proliferation with thrombosis and hemorrhages. 
Inves~igation of a series of alkyltin derivatives 
revealed that, with few exceptions, the toxicity of these 
compounds increases as the size of the alkyl group de-
creases and that trialkyl derivatives exhibit greater 
toxicity than their dialkyl counterparts (Stoner et al., 
1955). 
Trialkyltin compounds have been shown to produce 
interstitial edema of the white matter of the brain in 
rats (Magee et al., 1957) and inhibit oxidative phosphory-
lation in vitro (Aldridge and Cremer, 1955; Aldridge and 
Street, 1964, 1970, and 1971). Inhibition of muscular 
contractility in vitro associated with disruption of 
mitochondria, disorganization of muscle fibers and deple-
tion of neuromicrotubules has also been observed (Tan and 
Ng, 1977). 
Dialkyltin differ from trialkyltin compounds in that 
the primary lesion of these compounds is biliary and 
hepatic damage (Barnes and Stoner, 1958; Barnes and Magee, 
1958; Gaunt~ al., 1968). Dibutyltin is the most active 
of the dialkyltin series in this respect. Barnes and 
Magee (1958) reported bile duct damage and liver inflam-
mation two days after oral administration of dibutyltin 
dichloride (50 mg/kg for three days). After six months, 
the bile duct was shortened and thickened and hepatic 
portal fibrosis was evident. 
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EXPERIMENTAL 
Animals 
Male Long Evans rats weighing 250-350 grams were 
purchased from Charles River Breeding Laboratories, Inc. 
(Wilmington, MA). The rats were housed in groups of six 
in colony cages at an ambient temperature of 24-27° C. 
with alternating 12 hour light/dark cycles. Rats were 
fed Purina Laboratory Chow and water ad libitium. 
Materials 
Di-n-butyltin dichloride was purchased from 
Eastman Kodak Co. (Rochester, NY). The radioactive amino 
acids, 4-3H-proline (specific activity 25-30 Ci/mmole) 
and 2,3-JH-proline (specific activity 20 Ci/mmole) were 
purchased from New England Nuclear Corporation (Boston, 
MA). Bacterial collagenase, free of nonspecific proteases, 
was purchased from Advanced Biofactures (Lynbrook, NY). 
Eagles Minimum Essential Medium was obtained from Grand 
Island Biological Company (Grand Island, NY). Analytical 
grade reagents were used throughout the investigation. 
12 
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Cell Culture Technigues 
An established line of 1929 fibroblast cells were 
maintained in monolayer cultures in Eagles Minimum 
Essential Medium with 10% fetal calf serum and chlortetra-
cycline (50 ug/ml). Treated cell cultures were incubated 
with dibutyltin dichloride (0.1 mg/ml in 25% ethanol) 
during late log phase at final concentrations of J x 10-? M 
and J x 10-6 M. Control cultures received equivalent 
amounts of 25% ethanol. After 24 hours, medium was decanted 
and cells harvested by centrifugation following the addition 
of 0.1% trypsin. The pellet was washed three times with 
phosphate buffered saline and disrupted by ultrasonic 
energy (JO watts for two 15 second periods) in 1 ml 
0.25 M sucrose. Prolyl hydroxylase activity was determined 
in 50 and 100 ul aliquots of cell sonicates. 
Dibutyltin-Induced Hepatic Fibrosis 
Fibrosis and associated liver injury was produced 
in male Long Evans rats by the administration of dibutyl-
tin dichloride in corn oil by oral intubation. Dibutyltin 
dichloride was administered daily in animals treated for 
four days and every two days in animals treated for 12 
days. Rats were sacrificed by decapitation 24 hours after 
the last administration of dibutyltin dichloride. The 
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livers were removed and quickly chilled. Sections of 
liver tissue were fixed and prepared for light microscopy 
using hematoxylin-eosin and trichrome stains. Liver 
samples were also prepared for determination of prolyl 
hydroxylase activity and in vitro collagen synthesis. 
Remaining liver tissue was stored frozen for determination 
of hydroxyproline content. 
Hydroxyproline Determination 
Liver hydroxyproline content was determined using 
the method of Kivirikko et al. (1967) with some modifica-
tions. Acid hydrolyzates of liver were prepared by 
autoclaving 150 mg liver in 4 mls 6 N HCl for 24 hours. 
Following hydrolysis, samples were decolorized with acti-
vated charcoal, centrifuged at low speed (1000 rpm) and 
the resultant supernates filtered. Using phenolphthalein 
as an indicator, samples were adjusted to a pink color 
with 1 and 10 N potassium hydroxide. Aliquots containing 
J-15 ug hydroxyproline and hydroxyproline standards (5-
25 .ug) were diluted to 4 mls. The pH was again adjusted 
using phenolphthalein as an indicator and solutions were 
saturated with potassium chloride. One ml potassium 
borate buffer (pH 8.7) and 0.5 ml 10% alanine were added 
with mixing. After JO minutes samples were oxidized with 
1 ml 0.2 M chloramine-T solution at room temperature. 
The reaction was stopped after 25 minutes with 3 mls 
3.6 M sodium thiosulfate. Toluene-soluble oxidation 
products were extracted in 5 mls toluene and discarded. 
Pyrrole was formed from oxidation products of hydroxy-
proline remaining in solution by heating to 100° C for 
JO minutes. After cooling, pyrrole was extracted with 
5 mls toluene. The addition of 1 ml Ehrlich's reagent 
(p-dimethylaminobenzaldehyde) to 2.5 mls extract produced 
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a pyrrole chromophore after 30 minutes at r .oom temperature 
with a characteristic absorbance at 560 mu. 
Preparation of Substrate for Prolyl Hydroxylase Assay 
The tritium labeled substrate was prepared by the 
method of Hutton et al~ (1966) with some modifications. 
Twenty-five to thirty dozen, 7-day-old decapitated chick 
embryos were placed in ice-cold Krebs-Ringer buffera 
(Stone and Meister, 1962). After washing twice with 
ice-cold Krebs, embryos were minced in the presence of 
a small amount of ice-cold Krebs. Five to six gram 
portions of minced embryo were placed in 50 ml beakers 
and enough Krebs buffer was added to bring the final 
volume to 20 mls. Following the addition of 1.0 mci 
aNaCl, 1.285 g; KCl, 0.224 g; MgSO~, 0.144; CaC12 , 0.144 g: KH2Po4 , 0.544 g; NaHC0 1 , 2.10 g; D-Glucose, 1.80 g; and distilled water to ~liter. 
4-3H-proline and 20 ul of 1.0 M a ,a -dipyridyl, the 
mixture was incubated for two hours at 37° C under o2-co2 
(95/5%) in a metabolic shaker. After two hours, the 
embryo minces were centrifuged at J0,000 rpm for 90 
minutes and the supernates discarded. Newly synthesized 
collagen was extracted from the pellet with 0.5 M acetic 
acid (2 ml/gm tissue) overnight. After centrifugation 
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for 90 minutes at J0,000 rpm, the supernate containing 
newly-formed, unhydroxylated collagen was dialyzed against 
ten volumes of 0.01 M Tris HCl buffer (pH 7.4) with at 
least four changes. The substrate was then autoclaved 
for 15 minutes and redialyzed against three changes of 10 
volumes of Tris HCl buffer (pH 7.4). Substrate was then 
calibrated for specific activity and linearity with a 
standard purified rabbit enzyme (Chichester et al., 1976) 
and frozen in 10 ml aliquots. 
Prolyl Hydroxylase Activity 
Immediately after rats were sacrificed, livers were 
removed and 15-25 mg aliquots of tissue were homogenized 
in JOO ul of buffer containing 0.25 M sucrose, io-5 M 
ethylenediaminetetraacetic acid, 10-5 M dithiothreitol 
and 0.01% Triton. Prolyl hydroxylase activity in 50 and 
100 ul aliquots of homogenate was determined by the method 
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of Hutton et al. (1966) with some modifications. Aliquots 
of liver homogenates were incubated at 30° C for 30 min-
utes in a mixture containing approximately 600,000 cpm 
(depending on substrate batch) of tritiated substrate 
{0,2 ml), 0.5 mM ascorbate, 0.1 mM a-ketoglutarate, 
0.1 mM ferrous ammonium sulfate, 0.05 M Tris HCl buffer 
(pH 7.4), 0.2% bovine serum albumin and 0.02% catalase, 
The prolyl hydroxylase reaction was stopped after 30 
minutes by the addition of 0,1 volume 50% trichloroacetic 
acid. Tritiated water was then collected by vacuum distilla-
tion; a measured fraction of tritiated water was counted 
for radioactivity in a Packard Tri-Carb Liquid Scintillation 
Spectrometer (Model 3310). This radioactivity reflects 
the stoichiometric formation of hydroxyproline and tritiated 
water by prolyl hydroxylase in the presence of cofactors 
and labeled substrate as described above (Rhoads and 
Udenfriend, 1970), Due to variability in substrate batches, 
a conversion factor, derived from substrate calibration 
with standard enzyme, is employed to permit comparisons of 
prolyl hydroxylase activity values when different substrate 
preparations are used. 
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In Vitro Collagen Biosynthesis 
Collagen and noncollagen protein synthesis by liver 
tissue in vitro was determined by the method of Diegelmann 
et al. (1975) with modifications. Approximately 100 mg of 
freshly dissected liver minces were incubated for 24 hours 
at 37° C under o2-co2 (95/5%) in 4 mls of Eagles minimum 
essential medium containing 4-JH- or 2,J-JH-proline (50 
uci/ml), 10-4 M ascorbate and 50 ug/ml S -aminoproprio-
nitrile. Experiments have been conducted confirming that 
label incorporation into collagen and noncollagen protein 
is linear against time between 6 and 24 hours a the percent 
label in collagen does not change during this 24 hours. 
The incubation mixture was homogenized in a Bellco glass/ 
glass homogenizer and protein was precipitated by the addi-
tion of 0.1 volume 50% trichloroacetic acid at 4° c. The 
pellet, collected by centrifugation at 5,000 rpm for JO . 
minutes, was resuspended in 0.5 M acetic acid and dialyzed 
against 100 volumes of 0.5 M acetic acid with two changes 
and against 100 volumes of 0.05 M Tris HCl buffer (pH 7.4) 
with two changes to remove unincorporated labeled praline. 
Tubes of o.4 ml aliquots of sample were then incubated for 
18 hours at J7° C. in a mixture containing 0.05 M Tris HCl 
buffer . (pH 7.4), N-ethylmaleimide (2.5 umole), calcium 
chloride (0.5 umole), 0.1 ml chloroform and lJO units of 
bacterial collagenase. Duplicate tubes were incubated 
without collagenase, which served as enzyme blanks. 
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Following incubation, the reaction was stopped and protein 
was coprecipitated with 0.1 volume bovine serum albumin 
(1.0% ) by the addition of one volume 10% trichloroacetic 
acid. After JO minutes on ice, samples were centrifuged at 
5,000 rpm for JO minutes. The pellet was digested in 2 mls 
DigestolR (Yorktown, Hackensack, NJ) and counted in 10 mls 
toluene-based scintillation cocktail. The 5% trichloro-
acetic acid supernate was again coprecipitated using bovine 
serum albumin (1.0%) and counted in 10 mls HydromixR 
(Yorktown, Hackensack, NJ). Protein content was determined 
on liver homogenates. Collagen and noncollagen protein 
synthesis per unit protein was calculated from collagenase-
digested protein in the supernate and collagenase-resistant 
protein in the pellet, respectively. Relative collagen 
synthesis was calculated using a formula which accounted 
for the relative enrichment of collagen proline/hydroxy-
proline content (5.4 times) compared to noncollagen · pro-
tein (Diegelmann et al., 1975). 
Protein Determination 
Protein content was determined by the method of Lowry 
et al. (1951) using bovine serum albumin as the protein 
standard. The intensity of the characteristic blue color 
was read at 750 mu on a Gilford Model 250 Spectrophotometer. 
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Statistical Methods 
Students' t-test was used to test for significant 
differences between sample means. The sample means, 
standard errors of the means and t-statistics were calcu-
lated on an Olivetti-Underwood Programma 101 computer 
using the following formulae. 
a.) Arithmetic means of samples 
b.) Estimated standard error of the mean: 
" ., sl 
d'X = j N -1 1 1 
c.) t-statistica 
Acceptable level of significance in these studies was 
defined as P < 0.05 for a one-tailed t-test. 
RESULTS 
Cell Culture Investigation 
The effect of dibutyltin dichloride (DBT) on mouse 
fibroblasts in cell culture is shown in Table 1. When 
L929 fibroblasts were incubated with DBT at concent-
rations of 3 x 10-? M and 3 x 10-6 Mat late log phase, 
no change in prolyl hydroxylase activity in cell sonicates 
was observed compared to control values. 
Liver Hydroxyproline Content 
Since hydroxyproline does not appear in significant 
amounts in noncollagen protein, the amount of this amino 
acid reflects the amount of collagen present in liver 
tissue. The effect of DBT on liver hydroxyproline content 
in rats following treatment every two days for 12 days is 
shown in Table II. The amount of hydroxyproline, ex-
pressed as ug/mg liver wet weight, reflects measurement 
of the pyrrole chromophore of this amino acid in liver 
acid hydrolyzates. In the 10 mg/kg-treatment group, 
there was no change in liver hydroxyproline content. 
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Group 
Control 
TABLE I 
Effect of Dibutyltin (DBT) on Prolyl Hydroxylase 
a Activity in L - 929 Cells 
prolyl hydroxylase activityb 
cpm/ug protein 
54 
60 
DBT (3 x l0-7M) 56 
60 
DBT (3 x l0-6M) 47 
64 
alate log phase L-929 cells were incubated with DBT for 12 hours. 
bestimated by the formation of 3HHO from incubation at 30°C of 
4-3H-proline rich substrate and cofactors with 50 and 100 ul 
aliquots of cell sonicates prepared a·s : described in the methods. 
Each value represents mean of enzyme activity measurements from 
one flask of cells reported as cpm/ug protein/30 min. 
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TABLE II 
Effect of Dibutyltin (DBT) on Liver Hydroxyproline Content 
a in Rats After 12 Day~ of Treatment 
23 
Group Hydroxyprolinec 
ug/mg liver wet weight 
Control 
DBT (10 mg/kg) 
DBT (20 mg/kg) 
6 
7 
6 
0.125 + 0.004 
(range 0.105 - 0.133) 
0.148 + 0.019 
(range 0.102 - 0.249) 
0.266 + 0.044d 
(range O.l57 - 0.447) 
~BT in corn oil was administered every 2 days for 12 days by oral 
intubation; controls received equivalent amounts of corn oil. 
b N represents the number of rats in each group. 
c determinated colorimetrically in liver acid hydrolyzates as described 
in the methods • 
Values are mean + S.E.M. 
dp < 0.005 vs. control. 
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. However, DBT administration at the higher dose of 20 
mg/kg produced a greater than two-fold increase (p < 0.005) 
in the amount of hydroxyproline. 
Prolyl Hydroxylase Activity 
Since prolyl residues are not hydroxylated before 
they are in peptide-bound form and hydroxyproline does 
not occur to any significant extent in noncollagen 
protein, proline hydroxylation can be used as a measure 
of collagen synthesis in rat liver tissue. The effect 
of DBT on prolyl hydroxylase activity in rat liver 
homogenates after 4 and 12 days of treatment is seen in 
Tables III .and IV, respectively. Arter four days of 
DBT treatment, prolyl hydroxylase activity increased 
approximately 50'% (p < 0.01) in the 10 mg/kg group and 
about 130% (p < 0.01) in the 20 mg/kg group. Animals 
receiving the same doses of DBT every two days for 
12 days (Table IV) showed a relatively modest increase 
in prolyl hydroxylase activity. There was no change in 
prolyl hydroxylase activity in the 10 mg/kg group and 
an increase of approximately 50% (p < 0.05) in the 20 
mg/kg group. 
TABLE III 
Effect. of Dibutyltin (DBT) on Liver Prolyl Hydroxylase (PH) 
Activity in Rats After 4 Days of Treatment a 
Group 
Control 5 
DBT (10 mg/kg) 5 
DBT (20 mg/kg) 5 
c PH activity 
cpm/mg protein 
1129 + 94 
(range 85l-1297) 
1760 + 169d 
(range 1326-2226) 
2537 + 258d 
(range 1709-3095) 
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~BT in corn oil was administered daily. for 4 days by oral intubation; 
controls received equivalent amounts of corn oil. 
b N represents the number of rats in each group. 
cestimated by the formation of 3HHo from incubation at 30°c of 
4-3H-proline-rich substrate and cofactors with 50 and 100 ul 
aliquots of liver homogenates prepared as described in the methods 
and reported as cpm 3HHo/mg protein/30 min. 
Values are mean + S.E.M. 
d P < 0. 01 vs. control • 
TABLE IV 
Effect of Dibutyltin (DBT) on Liver Prolyl Hydroxylase (PH) 
Activity in Rats After 12 Days of Treatment a 
Group 
Control 12 
DBT (10 mg/kg) 15 
DBT (20 mg/kg) 12 
PH activityc 
cpm/mg protein 
2030 + 202 
(range 1290 - 3446) 
1873 + 95 
(range-1310 - 2517) 
3379 + 400 
d (range 1974 - -6527) 
~BT in corn oil was administered every 2 days for 12 days by oral 
intubation; controls received equivalent amounts of corn oil. 
bN represents the number of rats in each group. 
cestimated by the formation of 3HHo from incubation at 30°c of 
4-3H-proline-rich substrate and cofactors with 50 and 100 ul 
aliquots of liver ho~ogenates prepared as described in the methods 
and reported as cpm HHO/mg protein/30 min. 
Values are mean + S.E.M. 
dp < 0.05 vs. control. 
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In Vitro Collagen Synthesis 
Although prolyl hydroxylase activity is a sensitive 
indicator of increased fibrogenesis in liver homogenates, 
it has not been shown to be a rate-limiting step in 
collagen biosynthesis. A more direct indication of 
absolute and relative collagen synthesis is obtained by 
measurement of in vitro incorporation of JH-proline into 
collagenase-degradable and collagenase-resistant protein. 
The effect of DBT on in vitro collagen synthesis in 
rat liver tissue minces after 4 and 12 days of treatment 
is shown in Tables V and VI, respectively. After 4 days 
of DBT treatment at a dose of 20 mg/kg, the in vitro in-
corporation of labeled praline into collagenase-digestible 
protein increased approximately five-fold (p < 0,001). 
There was a concomitant increase in the amount of label 
incorporated into collagenase-resistant protein of approx-
imately the same magnitude. As a result, no significant 
change was observed in the percent of labeled protein 
digested by collagenase. DBT treatment every two days 
for 12 days (Table VI) at doses of 10 and 20 mg/kg 
produced a significant increase in the percent of collag-
enase-digestible protein at the higher dose only (p < 0.05). 
This increase reflects increased incorporation of labeled · 
proline into collagenase-digestible protein relative to de-
creased incorporation into collagenase-resistant protein. 
Group 
Control 
DBT 
(20 mg/kg) 
TABLE V 
In Vitro Collagen Synthesis in Rat Liver Tissue Minces 
a After 4 Days of Treatment With Dibutyltin (DBT) 
3 2,3 H-proline 3 2,3 H-proline 
released from incorporated into 
liver protein by collagenase-resistant 
Nb 
collagenase protein 
c c (cpm/mg protein) (cpm/mg protein) 
4 644 + 226 283,750 + 164,840 
7 3,098 ± 367d 1,606,840 ± 185,080d 
% of total 
labeled protein 
digested by 
c 
collagenase 
0.098 + 0.042 
0.039 + 0.006 
a DBT in corn oil was administered daily for 4 days by oral intubation; controls received 
equivalent amounts of corn oil . 
b N represents the number of rats in each group. 
c Collagenase digestion performed on protein obtained by precipitation with 5% trichloroacetic 
acid following 24 hour incubation with labeled praline as described in the methods. 
Values are mean + S.E.M. 
dp < 0.001 vs. control. 
N 
CX> 
GROUP Nb 
CONTROL 6 
DBT 7 
(10 mg/kg) 
DBT 5 
(20 mg/kg) 
TABLE VI 
In Vitro Collagen Synthesis in Rat Liver Tissue 
a Minces After 12 Days of Treatment With Dibutyltin (DBT) 
3 4 H-proline released 3 4 H-proline incorporated 
from liver protein into collagenase-resistant 
by collagenase protein 
c c (cpm/mg protein) (cpm/mg protein) 
307 + 81 19,200 + 3,000 
157 + 61 11,900 ± 5ood 
440 + 75 13,400 + 900d 
% of total 
labeled protein 
digested by 
collagenasec 
0.300 + 0.081 
0 . 282 + 0.100 
0.590 + 0.082d 
a DBT in corn oil was administered every 2 days for 12 days by oral intubation; controls received 
equivalent amounts of corn oil. 
b N represents the number of rats in each group. 
c Collagenase digestion performed on protein obtained by precipitation with 5% trichloroacetic 
acid following 24 hour incubation with labeled proline as described in the methods. 
d P < 0.05 vs . control. 
I\) 
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Body, Liver and Relative Liver Weights 
The effect of four days of DBT treatment (20 mg/kg) 
on weight gain is shown in Figure I. Dibutyltin-treated 
rats lost approximately eight grams per day resulting in 
a mean body weight which was 26% less (p < 0,001) than 
control animals. After DBT treatment every two days for 
12 days, the mean body weight was 12% less (p < 0.05) 
than control rats (Table VII). 
Histopathology 
Dibutyltin treatment at a dose of 20 mg/kg for 
four days produced inflammatory and biliary tract changes 
in rats. Inflammatory cells were observed throughout 
the portal tracts, most notably in and around bile ducts. 
Proliferation of bile ducts was evident at this time. 
At a dose of 10 mg/kg for four days, inflammation and 
biliary damage was minimal. 
After 12 days of DBT -treatment (20 mg/kg), inflam-
mation and biliary damage was extensive. Both mono-
nuclear and polymorphonuclear cells were present in and 
around portal tracts and extending out into parenchyma 
leaving only central vein areas preserved. Bile ducts 
were proliferated and congested with polymorphonuclear 
cells; damage to the bile duct epithelial cells was 
FIGURE I 
Effect of Dibutyltin on Rat Body Weighta 
3101 
300 
2901 
-
280J 0 I 
- I t- 0-0 CONTROL. (4) 
= 2701 s:! b-.t. DST (8) 
""' ~
261 
>-0 
0 ~01 m 
'] 23 c 
220 
DAYS 
aDibutyltin in corn oil (20 mg/kg) was administered 
every day for 4 days by oral intubation; controls 
received equivalent amounts of corn oil. 
Values are mean - S.E.M. 
bp < 0.01 vs. control 
cp < 0.001 vs. control 
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TABLE VII 
Ef feet of Dibutyltin on Body~, Liver and 
a Relative Liver Weights 
Relative 
N 
32 
Group 
Body 
Weight 
(g) 
Body 
Weight 
(g) 
Liver Weight b d 
(g liver/lOOg 0 .Yht) weig 
Control 6 384 + 14 12.85 + 0.94 3.33 + 0. 15 
DBT 
(10 mg/Kg) 7 382 + 6 13.01 + 0.60 3.40 + 0.12 
DBT 
339 + 14b (20 mg/Kg) 6 13.22 + 0.70 3.91 + 0.23 
~BT in corn oil was administered every 2 days for 12 days by oral 
intubation; controls received equivalent amounts of corn oil· 
b P< 0.05 vs. control. 
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appreciable. Areas of necrosis, both focal and confluent, 
were seen at this time. Large infarcted areas and non-
specific granulomatous lesions were present throughout 
the parenchyma. Finally, both periportal and paren-
chymal accumulation of fibrous tissue was demonstrated 
by trichrome stain. Treatment with 10 mg/kg DBT for 12 
days produced moderate inflammation and biliary damage, 
with minimal fibrosis and necrosis. 
DISCUSSION 
Biochemical and histological studies of DBT-treated 
rat livers after 12 days of treatment reveals increased 
accumulation of collagen which is associated with numerous 
histopathological changes. Histological observation of 
fibrous tissue and the greater than two-fold increase in 
hydroxyproline content following 20 mg/kg DBT treatment 
indicates the development of hepatic fibrosis which 
has not progressed to cirrhosis. There is no increase 
in hydroxyproline in the 10 mg/kg group and minimal histo-
logical evidence of fibrous tissue. The correlation 
between histologically demonstrable fibrous tissue and 
biochemically determined collagen is in agreement with 
that seen in dietary (Brunner et al., 1973) and carbon 
tetrachloride-induced cirrhosis (Rojkind, 1973). 
Biochemical data indicate only a moderate increase 
in hepatic collagen synthesis at 12 days when extensive 
fibrosis and necrosis are already established by histo-
pa thological criteria. The activity of prolyl hydroxylase 
is increased only 50% over controls, and there is no 
elevation in the amount of collagenase-digestible protein 
synthesized in vitro in liver biopsies. 
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The increased collagen accumulation at 12 days can, 
however, be attributed to an increase in relative, or 
percent, total protein synthesis directed toward collagen 
synthesis as a result of a significant decrease in the 
synthesis of noncollagen protein. The percent collagen 
synthesis in vitro is a comparison of collagen and non-
collagen synthesis per unit of protein. Histological 
observation suggests a decrease in viable areas of paren-
chyma and an increase in necrotic and fibrous tissue. 
This in turn would suggest a decrease in noncollagen-
prod uc ing cells with a resultant increase in collagen 
production per unit of protein. The two-fold increase 
in percent collagen synthesized in vitro shown in DBT-
treated livers after 12 days supports this conclusion. 
Since significant liver hydroxyproline accumulation 
is evident after 12 days of DBT treatment, the effect of 
DBT (10· and 20 mg/kg) on collagen synthesis in rat liver 
is investigated after only four days of treatment. Al-
though histological observation of liver biopsies with 
a collagen specific stain fails to show evidence of 
fibrosis at four days, biochemical studies demonstrate 
an increase in collagen synthesis. 
Prolyl hydroxylase activity in liver homogenates is 
increased greater than 50% and 130% in the 10 and 20 mg/kg 
DBT-treated rats, respectively. Increased activity of 
this enzyme has been shown to precede the increase in 
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hydroxyproline content in carbon tetrachloride-induced 
cirrhosis (Takeuchi et al., 1967) and histological 
evidence of advanced cirrhosis in human liver biopsies 
(Fuller et al., 1976; Fuller et al., 1977). The observed 
increase of prolyl hydroxylase activity in DBT-treated 
rat livers, therefore, suggests that fibrogenesis is 
increased at four days, prior to observable collagen 
accumulation. 
Additional evidence for increased collagen synthesis 
after four days of DBT treatment is seen in the six-fold 
increase in in vitro synthesis of collagenase-digestible 
protein • . There _ is no apparent enrichment in the amount of 
protein synthesis -directed to collagen because of a con-
comitant increase in noncollagen protein synthesis. How-
ever, this increase in n.oncollagen prate in synthesis may 
represent the protein made by inflammatory cells detected 
by light microscopy. 
The effect of DBT on fibroblasts is determined using 
monolayer cell cultures of 1929 fibroblasts. Prolyl 
hydroxylase activity is used as a measure of collagen 
synthesis in these cells. A direct correlation between 
the activity of this enzyme and the formation of hydroxy-
lated collagen has been reported by Gribble et al . (1969) 
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in cell cultures of L929 fibroblasts. That incubation 
with DBT had no effect on the activity of prolyl hydroxy-
lase in 1929 cells suggests that this compound does not 
directly stimulate collagen synthesis by fibroblasts 
in vivo and that the mechanism of DBT-induced hepatic 
f ibrogenesis requires a step intermediate to the direct 
stimulation of collagen-producing cells. 
The increased f ibrogenesis seen after four days of 
DBT treatment appears to be a sequela of inflammation 
and/or bile duct injury and proliferation, the only 
histopathological changes observed at this time. 
Diethyltin dichloride has been shown to decrease 
oxygen uptake in rat brain in vitro by binding to sulf-
hydral groups in a -keto acid oxidases with the resultant 
inhibition of these enzymes (Aldridge and Cremer, 1955). 
Since the presence of DBT has been demonstrated in the 
bile (Barnes and Magee, 1958), and dialkyltin compounds 
have many biological properties in common (Stoner et al., 
1954; Barnes and Stoner, 1961), DBT may produce its 
biliary damage by decreasing oxygen uptake, thereby pro-
ducing anoxia in bile duct epithelial cells. 
Further support for inflammation in portal tracts 
and bile duct damage being the primary lesion of DBT is 
presented by the histological picture after 12 days of 
treatment where the hepatocyte injury observed is 
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primarily peripheral. At this time, liver injury re-
sembles that of drug-induced hepatitis with necrosis and 
fibrosis (Leavy et al., 1976) with the exception of 
preserved centrilobular parenchyma. 
CONCLUSIONS 
(1) After four days of DBT treatment (20 mg/kg), 
histological observation of rat livers showed inflammation 
in portal tracts and bile duct inflammation and prolifera-
tion. Prolyl hydroxylase activity was increased 50 and 
1JO% over control values in the 10 and 20 mg/kg groups, 
respectively. The amount of in vitro collagen synthesis 
was increased five-fold in the higher dose group. There 
was, however, no change in percent collagen synthesis 
since noncollagen protein synthesis was also elevated 
five-fold, probably as a result of inflammatory cell 
protein synthesis. The data obtained indicate increased 
fibrogenesis at four days time although there is no 
evidence of fibrosis by histopa..thological criteria. 
(2) After 12 days of DBT treatment (20 mg/kg), 
there was extensive mononuclear and polymorphonuclear 
cell infiltration in portal tracts, particularly in and 
around bile ducts, and within the parenchyma. Unlike 
other forms of drug-induced hepatic injury, the central 
vein areas were preserved. There were focal and confluent 
areas of necrosis, infarcted areas, nonspecific granulo-
matous lesions and an accumulation of fibrous tissue. 
)9 
Increased collagen content was also reflected by ·the 
two-fold increase in hydroxyproline content. Prolyl 
hydroxylase activity was elevated only 50% over con-
trols and in vitro collagen synthesis was unchanged 
af'ter 12 days of treatment. However, percent collagen 
synthesis was increased two-fold. 
(J) DBT (J x 10-7 and J x lo-6 M) had no effect 
on prolyl hydroxylase activity of mouse fibroblasts 
in cell culture. 
(4) These results suggest that DBT-induced 
fibrogenesis is not a result of direct stimulation 
of fibroblasts and that biliary damage and/or inflam-
matory processes are responsible for increased f ibro-
genesis and associated histopathological changes. 
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